Project Description
Luoda is developing a unique oral liquid combination product to improve compliance and effectiveness.
Target
Congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid regurgitation) in dogs.
Project Details
| Development Status: | Clinical Development Ongoing |
| Licence Status: | First stage funding obtained |
| Commercialisation Date: | Estimated 2019 |